Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PCSA Processa Pharmaceuticals, Inc.

交易中 12-11 15:31:16 EST

0.2693

-0.0076

-2.74%

最高0.2818	最低0.2593	成交量99.52万
今开0.2818	昨收0.2769	日振幅8.13%
总市值1,525万	流通市值1,317万	总股本5,664万
成交额26.68万	换手率2.04%	流通股本4,890万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PCSA","market":"US","secType":"STK","nameCN":"Processa Pharmaceuticals, Inc.","latestPrice":0.2693,"timestamp":1765485034493,"preClose":0.2769,"halted":0,"volume":995241,"delay":0,"floatShares":48903400,"shares":56644223,"eps":-1.630961,"marketStatus":"交易中","change":-0.0076,"latestTime":"12-11 15:31:16 EST","open":0.2818,"high":0.2818,"low":0.2593,"amount":266777.89310796,"amplitude":0.081257,"askPrice":0.2698,"askSize":500,"bidPrice":0.2659,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-1.630961,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765486800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":0.2769,"preHourTrading":{"tag":"盘前","latestPrice":0.2781,"preClose":0.2769,"latestTime":"09:26 EST","volume":8154,"amount":2319.41573712,"timestamp":1765463198833},"postHourTrading":{"tag":"盘后","latestPrice":0.2778,"preClose":0.2769,"latestTime":"19:57 EST","volume":8452,"amount":2355.4976,"timestamp":1765414663421},"volumeRatio":1.179532},"requestUrl":"/m/hq/s/PCSA/tweets","defaultTab":"tweets","newsList":[{"id":"2586452280","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘急速下挫5.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586452280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586452280?lang=zh_cn&edition=full","pubTime":"2025-11-25 22:51","pubTimestamp":1764082286,"startTime":"0","endTime":"0","summary":"北京时间2025年11月25日22时51分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅下跌5.37%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.52%。其相关个股中，Lunai Bioworks Inc.、Autolus Therapeutics Plc、Biovie Inc C/Wts 08/08/2030涨幅较大，Clearmind Medicine Inc.、Lunai Bioworks Inc.、Pasithea Therapeutics Corp.较为活跃，换手率分别为225.13%、146.25%、24.64%，振幅较大的相关个股有Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Osr Holdings Inc C/Wts 09/02/2028 、Lixte Biotechnology Holdings, Inc.，振幅分别为38.79%、30.05%、19.02%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125225127977ece7a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251125225127977ece7a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2581020719","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581020719","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581020719?lang=zh_cn&edition=full","pubTime":"2025-11-07 01:06","pubTimestamp":1762448782,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日01时06分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.85%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.89%。其相关个股中，Surrozen Inc C/Wts 01/08/2031 、Iovance Biotherapeutics, Inc.、Tectonic Therapeutic, Inc.涨幅较大，Osr Holdings, Inc.、Enveric Biosciences, Inc.、Bio Green Med Solution, Inc.较为活跃，换手率分别为108.60%、17.11%、16.41%，振幅较大的相关个股有Cytomed Therapeutics Limited、Surrozen Inc C/Wts 01/08/2031 、Lixte Biotechnology Holdings  Inc C/Wts 30/11/2025 ，振幅分别为67.30%、53.54%、43.54%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110701062297589a67&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110701062297589a67&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2580247092","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2580247092","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580247092?lang=zh_cn&edition=full","pubTime":"2025-11-03 23:47","pubTimestamp":1762184845,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日23时47分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速下跌5.40%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为2.01%。其相关个股中，Terns Pharmaceuticals, Inc.、Phio Pharmaceuticals Corp.、Rein Therapeutics, Inc.涨幅较大，Phio Pharmaceuticals Corp.、Tharimmune, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为2241.89%、540.03%、363.81%，振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Tharimmune, Inc.、Phio Pharmaceuticals Corp.，振幅分别为142.59%、129.83%、66.82%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110323472694ec72a2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025110323472694ec72a2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2572583158","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.01%报0.190美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2572583158","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572583158?lang=zh_cn&edition=full","pubTime":"2025-10-01 00:48","pubTimestamp":1759250917,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日00时48分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速跳水5.01%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.38%。其相关个股中，Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Zura Bio Limited、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Qualigen Therapeutics, Inc.、Nls Pharmaceutics Ltd.较为活跃，换手率分别为2100.30%、320.12%、288.09%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Zura Bio Limited、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为84.00%、50.84%、46.54%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001004837a6a8cac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001004837a6a8cac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2570937028","title":"Processa Pharmaceuticals, Inc.盘中异动 快速上涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2570937028","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570937028?lang=zh_cn&edition=full","pubTime":"2025-09-27 03:57","pubTimestamp":1758916659,"startTime":"0","endTime":"0","summary":"北京时间2025年09月27日03时57分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.18%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，Applied Therapeutics, Inc.、Lexaria Bioscience Corp C/Wts 14/01/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Indaptus Therapeutics, Inc.、Soligenix, Inc.、Plus Therapeutics, Inc.较为活跃，换手率分别为1310.59%、154.63%、112.72%，振幅较大的相关个股有Indaptus Therapeutics, Inc.、Applied Therapeutics, Inc.、Yd Bio Ltd C/Wts 28/08/2030，振幅分别为162.20%、134.38%、68.00%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927035739954785eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250927035739954785eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2568128262","title":"Processa Pharmaceuticals, Inc.盘中异动 大幅跳水5.26%报0.197美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2568128262","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568128262?lang=zh_cn&edition=full","pubTime":"2025-09-20 00:29","pubTimestamp":1758299355,"startTime":"0","endTime":"0","summary":"北京时间2025年09月20日00时29分，Processa Pharmaceuticals, Inc.股票出现异动，股价急速下跌5.26%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920002915a72a99ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250920002915a72a99ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2567178474","title":"Processa Pharmaceuticals, Inc.盘中异动 临近收盘股价大涨5.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2567178474","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567178474?lang=zh_cn&edition=full","pubTime":"2025-09-16 03:40","pubTimestamp":1757965211,"startTime":"0","endTime":"0","summary":"北京时间2025年09月16日03时40分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速上涨5.49%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.11%。其相关个股中，Metavia Inc.、Monte Rosa Therapeutics, Inc.、C4 Therapeutics, Inc.涨幅较大，Salarius Pharmaceuticals, Inc.、Metavia Inc.、Atyr Pharma, Inc.较为活跃，换手率分别为590.19%、305.07%、148.30%，振幅较大的相关个股有Metavia Inc.、Revolution Medicines Inc C/Wts 17/12/2026 、Apollomics Inc C/Wts 01/04/2028 ，振幅分别为149.19%、66.63%、61.84%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916034011a722c097&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250916034011a722c097&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2566563935","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.06%报0.189美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2566563935","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566563935?lang=zh_cn&edition=full","pubTime":"2025-09-10 21:46","pubTimestamp":1757512001,"startTime":"0","endTime":"0","summary":"北京时间2025年09月10日21时46分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.06%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.49%。其相关个股中，Camp4 Therapeutics Corporation、Cdt Equity Inc C/Wts 22/09/2028、Revelation Biosciences Inc C/Wts 10/01/2027 涨幅较大，Revelation Biosciences, Inc.、Cdt Equity Inc.、Camp4 Therapeutics Corporation较为活跃，换手率分别为622.95%、183.19%、144.47%，振幅较大的相关个股有Camp4 Therapeutics Corporation、Lexaria Bioscience Corp C/Wts 14/01/2026 、Pmv Pharmaceuticals, Inc.，振幅分别为44.22%、29.30%、26.88%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910214641a71bf821&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250910214641a71bf821&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2558766037","title":"Processa Pharmaceuticals, Inc.盘中异动 急速跳水5.17%报0.220美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558766037","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558766037?lang=zh_cn&edition=full","pubTime":"2025-08-12 03:59","pubTimestamp":1754942373,"startTime":"0","endTime":"0","summary":"北京时间2025年08月12日03时59分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速下挫5.17%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.53%。其相关个股中，Equillium, Inc.、Entero Therapeutics Inc.、Bioxcel Therapeutics, Inc.涨幅较大，Entero Therapeutics Inc.、Equillium, Inc.、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为6288.70%、660.82%、631.13%，振幅较大的相关个股有Equillium, Inc.、Entero Therapeutics Inc.、Jyong Biotech Ltd.，振幅分别为84.05%、74.27%、70.12%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081203593394dd4a04&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081203593394dd4a04&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2557331980","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘急速上涨5.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2557331980","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557331980?lang=zh_cn&edition=full","pubTime":"2025-08-06 03:25","pubTimestamp":1754421944,"startTime":"0","endTime":"0","summary":"北京时间2025年08月06日03时25分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.84%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.58%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080603254494d1db6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025080603254494d1db6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2555634110","title":"Processa Pharmaceuticals, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555634110","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555634110?lang=zh_cn&edition=full","pubTime":"2025-07-30 00:40","pubTimestamp":1753807227,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日00时40分，Processa Pharmaceuticals, Inc.股票出现波动，股价急速下跌5.05%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.56%。其相关个股中，Salarius Pharmaceuticals, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Calidi Biotherapeutics, Inc.涨幅较大，Scinai Immunotherapeutics Ltd、Salarius Pharmaceuticals, Inc.、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为5449.40%、3555.12%、1699.10%，振幅较大的相关个股有Salarius Pharmaceuticals, Inc.、180 Life Sciences Corp C/Wts 07/11/2025、180 Life Sciences Corp.，振幅分别为161.91%、111.54%、75.60%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730004027a6c82d61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730004027a6c82d61&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2552784111","title":"Processa Pharmaceuticals, Inc.盘中异动 临近收盘急速上涨5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2552784111","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552784111?lang=zh_cn&edition=full","pubTime":"2025-07-17 04:00","pubTimestamp":1752696017,"startTime":"0","endTime":"0","summary":"北京时间2025年07月17日04时00分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.60%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为1.35%。其相关个股中，知临集团、Geovax Labs Inc C/Wts 29/09/2025、Barinthus Biotherapeutics Plc涨幅较大，Qualigen Therapeutics, Inc.、知临集团、Tnf Pharmaceuticals, Inc.较为活跃，换手率分别为2924.59%、2706.10%、1189.17%，振幅较大的相关个股有知临集团、Barinthus Biotherapeutics Plc、Qualigen Therapeutics, Inc.，振幅分别为334.61%、188.24%、80.45%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717040017a44f5055&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717040017a44f5055&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2551365133","title":"Processa Pharmaceuticals, Inc.盘中异动 下午盘快速下跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2551365133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551365133?lang=zh_cn&edition=full","pubTime":"2025-07-15 02:21","pubTimestamp":1752517300,"startTime":"0","endTime":"0","summary":"北京时间2025年07月15日02时21分，Processa Pharmaceuticals, Inc.股票出现波动，股价大幅下挫5.00%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.68%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.涨幅较大，Windtree Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.较为活跃，换手率分别为2101.83%、1334.34%、743.91%，振幅较大的相关个股有Sonnet Biotherapeutics Holdings, Inc.、Dare Bioscience, Inc.、Promis Neurosciences Inc.，振幅分别为217.02%、216.30%、210.04%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715022140a6a94e64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715022140a6a94e64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2550137504","title":"Processa Pharmaceuticals, Inc.7月8日成交额为219.95万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550137504","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550137504?lang=zh_cn&edition=full","pubTime":"2025-07-09 12:50","pubTimestamp":1752036643,"startTime":"0","endTime":"0","summary":"美东时间2025年7月8日，Processa Pharmaceuticals, Inc.成交额为219.95万美元，成交额较昨日增加168.90%，当日成交量为1049.07万股。Processa Pharmaceuticals, Inc.于2025年7月8日涨9.6%，报0.212美元，该股过去5个交易日涨3.61%，年初至今跌75.97%，过去60日跌19.85%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-08|219.95万|168.90%|1049.07万|#|2025-07-07|81.79万|48.69%|432.19万|#|2025-07-03|55.01万|-34.70%|284.99万|#|2025-07-02|84.25万|-39.17%|438.76万|#|2025-07-01|138.50万|30.82%|702.17万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125050a43f7a38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709125050a43f7a38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2549591655","title":"Processa Pharmaceuticals, Inc.7月7日成交额为81.79万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549591655","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549591655?lang=zh_cn&edition=full","pubTime":"2025-07-08 12:44","pubTimestamp":1751949849,"startTime":"0","endTime":"0","summary":"美东时间2025年7月7日，Processa Pharmaceuticals, Inc.成交额为81.79万美元，成交额较昨日增加48.69%，当日成交量为432.19万股。Processa Pharmaceuticals, Inc.于2025年7月7日跌0.51%，报0.194美元，该股过去5个交易日跌1.12%，年初至今跌78.08%，过去60日跌18.91%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-07|81.79万|48.69%|432.19万|#|2025-07-03|55.01万|-34.70%|284.99万|#|2025-07-02|84.25万|-39.17%|438.76万|#|2025-07-01|138.50万|30.82%|702.17万|#|2025-06-30|105.88万|-46.72%|510.08万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708124413a69c5387&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708124413a69c5387&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2548581821","title":"Processa Pharmaceuticals, Inc.7月2日成交额为84.25万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548581821","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548581821?lang=zh_cn&edition=full","pubTime":"2025-07-03 12:54","pubTimestamp":1751518457,"startTime":"0","endTime":"0","summary":"美东时间2025年7月2日，Processa Pharmaceuticals, Inc.成交额为84.25万美元，成交额较昨日减少39.17%，当日成交量为438.76万股。Processa Pharmaceuticals, Inc.于2025年7月2日跌5.75%，报0.189美元，该股过去5个交易日跌28.33%，年初至今跌78.68%，过去60日跌44.56%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-02|84.25万|-39.17%|438.76万|#|2025-07-01|138.50万|30.82%|702.17万|#|2025-06-30|105.88万|-46.72%|510.08万|#|2025-06-27|198.71万|3.84%|913.29万|#|2025-06-26|191.37万|-21.63%|783.04万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703125418a72be946&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250703125418a72be946&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2548859019","title":"Processa Pharmaceuticals, Inc.7月1日成交额为138.50万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548859019","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548859019?lang=zh_cn&edition=full","pubTime":"2025-07-02 12:42","pubTimestamp":1751431325,"startTime":"0","endTime":"0","summary":"美东时间2025年7月1日，Processa Pharmaceuticals, Inc.成交额为138.50万美元，成交额较昨日增加30.82%，当日成交量为702.17万股。Processa Pharmaceuticals, Inc.于2025年7月1日跌2.44%，报0.2美元，该股过去5个交易日跌30.8%，年初至今跌77.38%，过去60日跌36.1%。|近5个交易日成交情况||||#|日期|成交额（美元）|成交额较昨日变化|成交量（股）|#|2025-07-01|138.50万|30.82%|702.17万|#|2025-06-30|105.88万|-46.72%|510.08万|#|2025-06-27|198.71万|3.84%|913.29万|#|2025-06-26|191.37万|-21.63%|783.04万|#|2025-06-25|244.18万|-31.39%|906.38万|Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702124209a729c20e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702124209a729c20e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2547097259","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘大幅拉升5.30%报0.207美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2547097259","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547097259?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:31","pubTimestamp":1751290289,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分，Processa Pharmaceuticals, Inc.股票出现异动，股价快速拉升5.30%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.06%。其相关个股中，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 涨幅较大，Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃，换手率分别为2036.25%、111.29%、58.54%，振幅较大的相关个股有Artelo Biosciences, Inc.、Exicure, Inc.、Relmada Therapeutics, Inc.，振幅分别为27.63%、6.96%、6.56%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213129a4c6c43d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213129a4c6c43d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0},{"id":"2546475677","title":"Processa Pharmaceuticals, Inc.盘中异动 早盘股价大跌5.42%报0.225美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546475677","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546475677?lang=zh_cn&edition=full","pubTime":"2025-06-27 22:34","pubTimestamp":1751034876,"startTime":"0","endTime":"0","summary":"北京时间2025年06月27日22时34分，Processa Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.42%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.07%。其相关个股中，Inmune Bio Inc.、Nls Pharmaceutics Ltd C/Wts 02/02/2026、天境生物涨幅较大，Inmune Bio Inc.、Adial Pharmaceuticals, Inc、Conduit Pharmaceuticals Inc.较为活跃，换手率分别为113.98%、51.22%、28.65%，振幅较大的相关个股有Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Channel Therapeutics Corporation、Inmune Bio Inc.，振幅分别为74.75%、62.62%、43.63%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627223436952e3b27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250627223436952e3b27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PCSA","BK4007"],"gpt_icon":0},{"id":"2545417801","title":"Processa Pharmaceuticals, Inc.股价重挫18.03% 市值跌56.22万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545417801","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545417801?lang=zh_cn&edition=full","pubTime":"2025-06-23 21:32","pubTimestamp":1750685546,"startTime":"0","endTime":"0","summary":"北京时间2025年06月23日21时32分，Processa Pharmaceuticals, Inc.股票出现波动，股价快速下挫18.03%。Processa Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.26%。其相关个股中，Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cidara Therapeutics, Inc.涨幅较大，Indaptus Therapeutics, Inc.、Impact Biomedical, Inc.、Nucana Plc较为活跃，换手率分别为894.81%、893.45%、198.91%，振幅较大的相关个股有Impact Biomedical, Inc.、Indaptus Therapeutics, Inc.、Cero Therapeutics Holdings, Inc.，振幅分别为30.38%、16.07%、14.61%。Processa Pharmaceuticals, Inc.公司简介：Processa Pharmaceuticals Inc是一家临床阶段的生物制药公司，专注于利用其监管科学方法开发下一代化疗肿瘤药物产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213226a718f131&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623213226a718f131&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","PCSA"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.processapharmaceuticals.com","stockEarnings":[{"period":"1week","weight":0.0371},{"period":"1month","weight":-0.1979},{"period":"3month","weight":0.4429},{"period":"6month","weight":0.0712},{"period":"1year","weight":-0.7918},{"period":"ytd","weight":-0.6867}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":0.009},{"period":"3month","weight":0.0455},{"period":"6month","weight":0.1517},{"period":"1year","weight":0.1406},{"period":"ytd","weight":0.1732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Processa Pharmaceuticals, Inc.成立于2011年3月29日。该公司是一家临床阶段的生物制药公司，致力于药物产品的开发，该产品旨在为高度未满足的患者提供治疗方法并改善其生存率和生活质量。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.248045},{"month":2,"riseRate":0.571429,"avgChangeRate":0.073235},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.127227},{"month":4,"riseRate":0.142857,"avgChangeRate":-0.105856},{"month":5,"riseRate":0.375,"avgChangeRate":-0.066944},{"month":6,"riseRate":0.625,"avgChangeRate":0.111789},{"month":7,"riseRate":0.25,"avgChangeRate":-0.092403},{"month":8,"riseRate":0.25,"avgChangeRate":-0.103684},{"month":9,"riseRate":0.625,"avgChangeRate":0.090282},{"month":10,"riseRate":0.25,"avgChangeRate":0.024981},{"month":11,"riseRate":0.375,"avgChangeRate":0.039964},{"month":12,"riseRate":0.375,"avgChangeRate":-0.139532}],"exchange":"NASDAQ","name":"Processa Pharmaceuticals, Inc.","nameEN":"Processa Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Processa Pharmaceuticals, Inc.,PCSA,Processa Pharmaceuticals, Inc.股票,Processa Pharmaceuticals, Inc.股票老虎,Processa Pharmaceuticals, Inc.股票老虎国际,Processa Pharmaceuticals, Inc.行情,Processa Pharmaceuticals, Inc.股票行情,Processa Pharmaceuticals, Inc.股价,Processa Pharmaceuticals, Inc.股市,Processa Pharmaceuticals, Inc.股票价格,Processa Pharmaceuticals, Inc.股票交易,Processa Pharmaceuticals, Inc.股票购买,Processa Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Processa Pharmaceuticals, Inc.(PCSA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Processa Pharmaceuticals, Inc.(PCSA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}

公司概况